FDA won’t approve the psychedelic drug MDMA for PTSD, calling for more research on its safety and effectiveness

WASHINGTON (AP) — FDA won’t approve the psychedelic drug MDMA for PTSD, calling for more research on its safety and effectiveness.

Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

Federal News Network Logo
Log in to your WTOP account for notifications and alerts customized for you.

Sign up